Clinical Trial Update: Efficacy and Tolerance of Solriamfetol in Patients Affected with Idiopathic Hypersomnia. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and tolerance of solriamfetol in idiopathic hypersomnia; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Hypersomnia

Drugs mentioned

• Solriamfetol (solriamfetol)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Idiopathic Hypersomnia | Phase 2 | Status: NOT_YET_RECRUITING